Co-Diagnostics Inc (CODX)

$1.26 -0.08 (-5.97%)
Market Cap 4.94M
Revenue (ttm) 620,000.00
Net Income (ttm) -46.90M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -7,564.52%
Debt to Equity Ratio 0.00
Volume 385,100
Avg Vol 490,942
Day's Range N/A - N/A
Shares Out 3.69M
Stochastic %K 0%
Beta 2.88
Analysts Hold
Price Target $45.00

Company Profile

Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers Co-Dx PCR platform, a polymerase chain reaction testing to patients in point-of-care and at-home setting. The company also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, malaria, dengue, hum...

Industry: Medical Devices
Sector: Healthcare
Phone: 801 438 1036
Website: co-dx.com
Address:
2401 S. Foothill Drive, Suite D, Salt Lake City, United States
Bleedner
Bleedner Aug. 19 at 12:15 PM
$YJ $CODX 2 different sectors, I will bank on both of them. Mark it
0 · Reply
Bleedner
Bleedner Aug. 19 at 12:12 PM
$ARCT $VRAX $CODX All getting attention as MRNA sympathy plays
0 · Reply
Antiquarian
Antiquarian Aug. 19 at 12:06 PM
$CODX Posted 19 miserable hours ago “Subject to FDA clearance, Co-D is preparing for a potential U.S. launch of the platform, while also pursuing regulatory authorizations internationally and working toward the broader goal of expanding access to PCR diagnostics around the world. We appreciate the opportunity to join other industry leaders for an important conversation about technologies, trends and challenges shaping the next chapter of medical devices and innovation.” https://lnkd.in/p/eUn43XMr
0 · Reply
CoffeeRocks
CoffeeRocks Aug. 19 at 10:25 AM
$CODX https://share.google/piVnHyjnJ8HQpf69y
0 · Reply
ShangVXO
ShangVXO Aug. 19 at 9:20 AM
Been tapped into @_ProfessorGamma for a minute now. The way they spot some of these plays before they run is nuts! Wise to be paying attention to this account, give him a proper follow 👍 $LICN and $CODX can boom
0 · Reply
Dovkav
Dovkav Aug. 19 at 1:53 AM
$CODX covid is spreading. Hopefully it's good news for codx
1 · Reply
Stealth80
Stealth80 Aug. 18 at 10:46 PM
$CODX post 1/2 Before voting FOR everything simply because the Board recommends it, make sure you understand what you are approving. Here is what the six proposals actually mean: 1. Directors — BE CAREFUL You are voting on five individual Board members. You can vote for each director separately. The Board recommends FOR all five. 2. Equity Incentive Plan — PAY ATTENTION A FOR vote increases the number of common shares available for awards under the 2025 Equity Incentive Plan. This means shareholders are being asked to authorize additional shares for equity compensation. 3. Executive Compensation — PAY ATTENTION A FOR vote means supporting, on an advisory basis, the compensation paid to the Company’s named executive officers as described in the Proxy Statement.
1 · Reply
Stealth80
Stealth80 Aug. 18 at 10:45 PM
$CODX post 2/2 4. Auditor — PROCEDURAL A vote to ratify Tanner LLC as the Company's independent registered public accounting firm for 2026. 5. Quorum — PROCEDURAL A FOR vote changes the Articles of Incorporation so that one-third of the voting power constitutes a quorum. 6. Adjournment — PROCEDURAL A FOR vote allows the Annual Meeting to be postponed or adjourned if necessary to allow additional solicitation and voting of proxies in favor of the proposals. The Board recommends FOR all six proposals. So before clicking FOR ALL, read what you are actually approving. I am not telling anyone how to vote. I am simply pointing out that shareholders should not automatically approve every proposal without understanding its consequences. Read the Proxy. Understand the proposals. Then vote accordingly.
1 · Reply
MarioKou
MarioKou Aug. 18 at 10:24 PM
$CODX it's cold and lonely in here.
1 · Reply
FilthyPeasant
FilthyPeasant Aug. 18 at 7:38 PM
$CODX Study published recently in India which points out the large gap between TB diagnostic demand and the existing diagnostic infrastructure. Explicitly states the need for TB diagnostics technology at the point of primary care, essentially calling for our technology to be rolled out. It will be soon! Something like 25 million PCR TB tests/year are needed in the near future for India to transition from a 100 years old technique that nobody uses anymore. Looking forward to CDSCO approval news as the next big domino! https://theprint.in/ani-press-releases/indias-tb-elimination-goal-needs-stronger-diagnostic-infrastructure-at-the-point-of-care-peer-reviewed-study/3014647/
2 · Reply
Latest News on CODX
Co-Diagnostics Participates in Medical Devices and Innovations Roundtable Media Event

Aug 18, 2026, 9:30 AM EDT - 22 hours ago

Co-Diagnostics Participates in Medical Devices and Innovations Roundtable Media Event

Co-Diagnostics Earnings Call Transcript: Q2 2026

Aug 13, 2026, 4:30 PM EDT - 5 days ago

Co-Diagnostics Earnings Call Transcript: Q2 2026

Co-Diagnostics Earnings release: Q2 2026

Aug 13, 2026, 4:30 PM EDT - 5 days ago

Co-Diagnostics Earnings release: Q2 2026

Co-Diagnostics Quarterly report: Q2 2026

Aug 13, 2026, 4:30 PM EDT - 5 days ago

Co-Diagnostics Quarterly report: Q2 2026

Co-Diagnostics Reports Second Quarter 2026 Financial Results

Aug 13, 2026, 4:01 PM EDT - 5 days ago

Co-Diagnostics Reports Second Quarter 2026 Financial Results

Co-Diagnostics submits FDA 510(k) premarket notification for Co-Dx PCR Flu test

2026-08-06T13:36:10.000Z - 12 days ago

Co-Diagnostics submits FDA 510(k) premarket notification for Co-Dx PCR Flu test

Co-Diagnostics Submits FDA 510(k) Premarket Notification for Upper Respiratory Point-of-Care Test

Aug 6, 2026, 9:30 AM EDT - 12 days ago

Co-Diagnostics Submits FDA 510(k) Premarket Notification for Upper Respiratory Point-of-Care Test

Co-Diagnostics Announces Second Quarter 2026 Earnings Release Date and Webcast

Jul 30, 2026, 9:00 AM EDT - 19 days ago

Co-Diagnostics Announces Second Quarter 2026 Earnings Release Date and Webcast

Co-Diagnostics joint venture CoSara provides ebola test kits for India studies

2026-07-28T12:10:57.000Z - 22 days ago

Co-Diagnostics joint venture CoSara provides ebola test kits for India studies

Co-Diagnostics Joint Venture CoSara Provides Ebola Test Kits for Analytical Studies

Jul 28, 2026, 8:00 AM EDT - 22 days ago

Co-Diagnostics Joint Venture CoSara Provides Ebola Test Kits for Analytical Studies

Co-Diagnostics Joint Venture CoSara Initiates Clinical Studies in India for Tuberculosis Test on PCR Platform

Jul 22, 2026, 9:00 AM EDT - 27 days ago

Co-Diagnostics Joint Venture CoSara Initiates Clinical Studies in India for Tuberculosis Test on PCR Platform

Co-Diagnostics Proxy statement: Proxy filing

Jul 21, 2026, 8:00 AM EDT - 4 weeks ago

Co-Diagnostics Proxy statement: Proxy filing

Co-Diagnostics appoints Wes Lindsey as Chief Scientific Officer

2026-07-16T13:05:10.000Z - 4 weeks ago

Co-Diagnostics appoints Wes Lindsey as Chief Scientific Officer

Co-Diagnostics Appoints Wes Lindsey, PhD, MBA as Chief Scientific Officer

Jul 16, 2026, 9:00 AM EDT - 4 weeks ago

Co-Diagnostics Appoints Wes Lindsey, PhD, MBA as Chief Scientific Officer

Co-Diagnostics Proxy statement: Proxy filing

Jul 10, 2026, 8:00 AM EDT - 5 weeks ago

Co-Diagnostics Proxy statement: Proxy filing

Co-Diagnostics Invited to Participate in NPOC Tuberculosis Diagnostics Workshop in Bangkok, Thailand

Jul 8, 2026, 9:00 AM EDT - 5 weeks ago

Co-Diagnostics Invited to Participate in NPOC Tuberculosis Diagnostics Workshop in Bangkok, Thailand

Co-Diagnostics Completes Clinical and Analytical Studies in Preparation for FDA 510(k) Submission of Upper Respiratory Point-of-Care Test

Jul 1, 2026, 9:00 AM EDT - 6 weeks ago

Co-Diagnostics Completes Clinical and Analytical Studies in Preparation for FDA 510(k) Submission of Upper Respiratory Point-of-Care Test

Co-Diagnostics Vector Smart® Division Expands Footprint to 21 States

Jun 25, 2026, 9:00 AM EDT - 7 weeks ago

Co-Diagnostics Vector Smart® Division Expands Footprint to 21 States

Co-Diagnostics signs distribution agreement for CO-Dx PCR Pro in Mexico

2026-06-11T13:08:40.000Z - 2 months ago

Co-Diagnostics signs distribution agreement for CO-Dx PCR Pro in Mexico

Co-Diagnostics Advances Latin American Commercialization Strategy for Co-Dx™ PCR Pro® with Mexico Distributor Agreement

Jun 11, 2026, 9:00 AM EDT - 2 months ago

Co-Diagnostics Advances Latin American Commercialization Strategy for Co-Dx™ PCR Pro® with Mexico Distributor Agreement

Co-Diagnostics announces continued progress in Ebola PCR development program

2026-06-02T14:52:18.000Z - 2 months ago

Co-Diagnostics announces continued progress in Ebola PCR development program

Co-Diagnostics trading halted, volatility trading pause

2026-06-02T14:07:28.000Z - 2 months ago

Co-Diagnostics trading halted, volatility trading pause

Co-Diagnostics trading resumes

2026-06-02T13:54:50.000Z - 2 months ago

Co-Diagnostics trading resumes

Co-Diagnostics and CoSara Advance Ebola PCR Test Development and Co-Dx™ PCR Point-of-Care Platform Capabilities

Jun 2, 2026, 9:00 AM EDT - 2 months ago

Co-Diagnostics and CoSara Advance Ebola PCR Test Development and Co-Dx™ PCR Point-of-Care Platform Capabilities

Co-Diagnostics files to sell 4.94M shares of common stock for holders

2026-05-28T21:18:09.000Z - 2 months ago

Co-Diagnostics files to sell 4.94M shares of common stock for holders

Co-Diagnostics Registration statement: Registration filing

May 28, 2026, 8:00 AM EDT - 2 months ago

Co-Diagnostics Registration statement: Registration filing

Co-Diagnostics trading halted, volatility trading pause

2026-05-27T15:15:44.000Z - 2 months ago

Co-Diagnostics trading halted, volatility trading pause

Co-Diagnostics trading resumes

2026-05-27T15:08:07.000Z - 2 months ago

Co-Diagnostics trading resumes

Co-Diagnostics and CoSara Diagnostics advance with ebola PCR development

2026-05-26T14:04:46.000Z - 3 months ago

Co-Diagnostics and CoSara Diagnostics advance with ebola PCR development

Co-Diagnostics Advances Ebola PCR Assay Development Strategy with Joint Venture CoSara

May 26, 2026, 9:00 AM EDT - 3 months ago

Co-Diagnostics Advances Ebola PCR Assay Development Strategy with Joint Venture CoSara

Co-Diagnostics Announces $3.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules

May 19, 2026, 10:54 PM EDT - 3 months ago

Co-Diagnostics Announces $3.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Co-Diagnostics develops ebola assay strategy after recent global outbreak alert

2026-05-19T13:16:13.000Z - 3 months ago

Co-Diagnostics develops ebola assay strategy after recent global outbreak alert

Co-Diagnostics Develops Ebola Assay Strategy Following Recent Global Outbreak Alert

May 19, 2026, 9:00 AM EDT - 3 months ago

Co-Diagnostics Develops Ebola Assay Strategy Following Recent Global Outbreak Alert

Co-Diagnostics reports Q1 EPS ($4.06) vs. ($7.05) last year

2026-05-14T21:49:36.000Z - 3 months ago

Co-Diagnostics reports Q1 EPS ($4.06) vs. ($7.05) last year

Co-Diagnostics Earnings Call Transcript: Q1 2026

May 14, 2026, 4:30 PM EDT - 3 months ago

Co-Diagnostics Earnings Call Transcript: Q1 2026

Co-Diagnostics Earnings release: Q1 2026

May 14, 2026, 4:30 PM EDT - 3 months ago

Co-Diagnostics Earnings release: Q1 2026

Co-Diagnostics Quarterly report: Q1 2026

May 14, 2026, 4:30 PM EDT - 3 months ago

Co-Diagnostics Quarterly report: Q1 2026

Co-Diagnostics Reports First Quarter 2026 Financial Results

May 14, 2026, 4:01 PM EDT - 3 months ago

Co-Diagnostics Reports First Quarter 2026 Financial Results

Co-Diagnostics Slides: Investor presentation

May 14, 2026, 4:00 PM EDT - 3 months ago

Co-Diagnostics Slides: Investor presentation

Co-Diagnostics files $150M mixed securities shelf

2026-05-12T20:55:31.000Z - 3 months ago

Co-Diagnostics files $150M mixed securities shelf

Co-Diagnostics Registration statement: Registration filing

May 12, 2026, 8:00 AM EDT - 3 months ago

Co-Diagnostics Registration statement: Registration filing

Co-Diagnostics’ joint venture with CoMira finalizes facility lease agreement

2026-05-08T15:28:11.000Z - 3 months ago

Co-Diagnostics’ joint venture with CoMira finalizes facility lease agreement

Co-Diagnostics Joint Venture CoMira Finalizes Lease Agreement for Manufacturing Facility in Saudi Arabia's Sudair Industrial City

May 8, 2026, 9:00 AM EDT - 3 months ago

Co-Diagnostics Joint Venture CoMira Finalizes Lease Agreement for Manufacturing Facility in Saudi Arabia's Sudair Industrial City

Co-Diagnostics Announces First Quarter 2026 Earnings Release Date and Webcast

Apr 30, 2026, 9:00 AM EDT - 3 months ago

Co-Diagnostics Announces First Quarter 2026 Earnings Release Date and Webcast

Co-Diagnostics Invited to Present at Stop TB Partnership Summit in Washington, D.C.

Apr 16, 2026, 9:00 AM EDT - 4 months ago

Co-Diagnostics Invited to Present at Stop TB Partnership Summit in Washington, D.C.

Co-Diagnostics to Showcase Co-Dx PCR Platform and CE-IVD Solutions at ESCMID 2026 in Munich, Germany

Apr 14, 2026, 9:00 AM EDT - 4 months ago

Co-Diagnostics to Showcase Co-Dx PCR Platform and CE-IVD Solutions at ESCMID 2026 in Munich, Germany

Co-Diagnostics Executives to Participate in European Trade Mission with Utah Governor and WTC Utah

Apr 9, 2026, 9:00 AM EDT - 4 months ago

Co-Diagnostics Executives to Participate in European Trade Mission with Utah Governor and WTC Utah

Co-Diagnostics Earnings Call Transcript: Q4 2025

Mar 31, 2026, 4:30 PM EDT - 5 months ago

Co-Diagnostics Earnings Call Transcript: Q4 2025

Co-Diagnostics Annual report: Q4 2025

Mar 31, 2026, 4:30 PM EDT - 5 months ago

Co-Diagnostics Annual report: Q4 2025

Co-Diagnostics Earnings release: Q4 2025

Mar 31, 2026, 4:30 PM EDT - 5 months ago

Co-Diagnostics Earnings release: Q4 2025

Co-Diagnostics Reports Full Year 2025 Financial Results

Mar 31, 2026, 4:01 PM EDT - 5 months ago

Co-Diagnostics Reports Full Year 2025 Financial Results

Co-Diagnostics Ships Diagnostic Materials to India for Initiation of Tuberculosis Clinical Studies Following Recently Issued Guidance from the World Health Organization

Mar 25, 2026, 8:00 AM EDT - 5 months ago

Co-Diagnostics Ships Diagnostic Materials to India for Initiation of Tuberculosis Clinical Studies Following Recently Issued Guidance from the World Health Organization

Co-Diagnostics to expand commercial, distribution territory across South Asia

2026-03-20T12:11:57.000Z - 5 months ago

Co-Diagnostics to expand commercial, distribution territory across South Asia

Co-Diagnostics Signs Agreement to Significantly Expand Commercial and Distribution Territory Across South Asia

Mar 20, 2026, 8:00 AM EDT - 5 months ago

Co-Diagnostics Signs Agreement to Significantly Expand Commercial and Distribution Territory Across South Asia

Co-Diagnostics Announces Fourth Quarter and Full Year 2025 Earnings Release Date and Webcast

Mar 17, 2026, 9:00 AM EDT - 5 months ago

Co-Diagnostics Announces Fourth Quarter and Full Year 2025 Earnings Release Date and Webcast

Co-Diagnostics to Present at Medical Korea 2026

Mar 16, 2026, 9:00 AM EDT - 5 months ago

Co-Diagnostics to Present at Medical Korea 2026

Co-Diagnostics Receives Japanese Patent Covering Co-Dx PCR Platform Technologies

Mar 12, 2026, 9:00 AM EDT - 5 months ago

Co-Diagnostics Receives Japanese Patent Covering Co-Dx PCR Platform Technologies

Co-Diagnostics Regains Compliance with Nasdaq Listing Requirements

Mar 10, 2026, 9:00 AM EDT - 5 months ago

Co-Diagnostics Regains Compliance with Nasdaq Listing Requirements

Co-Diagnostics to Showcase PCR Platform at World Health Expo Labs Dubai

Feb 9, 2026, 9:00 AM EST - 6 months ago

Co-Diagnostics to Showcase PCR Platform at World Health Expo Labs Dubai

Co-Diagnostics Joint Venture CoSara Receives CDSCO License to Manufacture and Sell CoSara PCR Pro™ Instrument

Feb 5, 2026, 9:00 AM EST - 6 months ago

Co-Diagnostics Joint Venture CoSara Receives CDSCO License to Manufacture and Sell CoSara PCR Pro™ Instrument

Co-Diagnostics JV, CoSara, Receives ISO 13485 Certification in Preparation for Manufacturing Upcoming PCR Platform

Feb 4, 2026, 9:00 AM EST - 6 months ago

Co-Diagnostics JV, CoSara, Receives ISO 13485 Certification in Preparation for Manufacturing Upcoming PCR Platform

Co-Diagnostics cut to Hold at Maxim on Nasdaq delisting

2026-01-23T14:10:52.000Z - 7 months ago

Co-Diagnostics cut to Hold at Maxim on Nasdaq delisting

Co-Diagnostics JV CoSara Participates in Regional Conferences to Grow and Strengthen Distributor Relationships

Jan 12, 2026, 9:00 AM EST - 7 months ago

Co-Diagnostics JV CoSara Participates in Regional Conferences to Grow and Strengthen Distributor Relationships

Co-Diagnostics Announces Reverse Stock Split

Dec 30, 2025, 9:00 AM EST - 8 months ago

Co-Diagnostics Announces Reverse Stock Split

Co-Diagnostics Receives Grant of Australian Patent Covering Co-Dx PCR Platform Technologies

Dec 29, 2025, 9:00 AM EST - 8 months ago

Co-Diagnostics Receives Grant of Australian Patent Covering Co-Dx PCR Platform Technologies

Co-Diagnostics Joint Venture, CoSara, Invited to Participate in 2nd Advanced TB Diagnostics Course in Chennai, India

Dec 18, 2025, 9:00 AM EST - 8 months ago

Co-Diagnostics Joint Venture, CoSara, Invited to Participate in 2nd Advanced TB Diagnostics Course in Chennai, India

Co-Diagnostics Performs Analysis of Influenza Co-Primers® to Confirm Reactivity Against Flu A H3N2 Mutation

Dec 17, 2025, 9:00 AM EST - 8 months ago

Co-Diagnostics Performs Analysis of Influenza Co-Primers® to Confirm Reactivity Against Flu A H3N2 Mutation

Co-Diagnostics to Present on Co-Dx™ PCR Platform and AI Integration at Point-of-Care Testing 2025

Dec 9, 2025, 9:00 AM EST - 9 months ago

Co-Diagnostics to Present on Co-Dx™ PCR Platform and AI Integration at Point-of-Care Testing 2025

Co-Diagnostics JV, CoSara, to Participate at VIROCON 2025 in Pune, India

Dec 8, 2025, 12:36 PM EST - 9 months ago

Co-Diagnostics JV, CoSara, to Participate at VIROCON 2025 in Pune, India

Co-Diagnostics Delivers Address about Tuberculosis Test Adoption and Implementation at The Union World Conference on Lung Health

Nov 20, 2025, 9:00 AM EST - 9 months ago

Co-Diagnostics Delivers Address about Tuberculosis Test Adoption and Implementation at The Union World Conference on Lung Health

Co-Diagnostics Initiates Clinical Evaluations for Upper Respiratory Multiplex Point-of-Care Test on Co-Dx™ PCR Platform to Support Submission to the U.S. FDA

Nov 18, 2025, 9:00 AM EST - 9 months ago

Co-Diagnostics Initiates Clinical Evaluations for Upper Respiratory Multiplex Point-of-Care Test on Co-Dx™ PCR Platform to Support Submission to the U.S. FDA

Co-Diagnostics Earnings Call Transcript: Q3 2025

Nov 13, 2025, 4:30 PM EST - 9 months ago

Co-Diagnostics Earnings Call Transcript: Q3 2025

Co-Diagnostics Quarterly report: Q3 2025

Nov 13, 2025, 4:30 PM EST - 9 months ago

Co-Diagnostics Quarterly report: Q3 2025

Co-Diagnostics Earnings release: Q3 2025

Nov 13, 2025, 4:30 PM EST - 9 months ago

Co-Diagnostics Earnings release: Q3 2025

Co-Diagnostics Reports Third Quarter 2025 Financial Results

Nov 13, 2025, 4:01 PM EST - 9 months ago

Co-Diagnostics Reports Third Quarter 2025 Financial Results

Co-Diagnostics Proxy statement: Proxy Filing

Nov 10, 2025, 7:00 AM EST - 10 months ago

Co-Diagnostics Proxy statement: Proxy Filing

Co-Diagnostics Transcript: Fireside Chat

Nov 5, 2025, 11:00 AM EST - 10 months ago

Co-Diagnostics Transcript: Fireside Chat

Co-Diagnostics Engages Maxim Group to Pursue SPAC Transaction for its Indian Joint Venture, CoSara Diagnostics Pvt. Ltd

Nov 5, 2025, 9:00 AM EST - 10 months ago

Co-Diagnostics Engages Maxim Group to Pursue SPAC Transaction for its Indian Joint Venture, CoSara Diagnostics Pvt. Ltd

Co-Diagnostics to Integrate and Implement Proprietary Artificial Intelligence Technology into Co-Dx™ Primer Ai™ Platform

Nov 3, 2025, 9:00 AM EST - 10 months ago

Co-Diagnostics to Integrate and Implement Proprietary Artificial Intelligence Technology into Co-Dx™ Primer Ai™ Platform

Co-Diagnostics, Inc. Announces Third Quarter 2025 Earnings Release Date and Webcast

Oct 31, 2025, 9:00 AM EDT - 10 months ago

Co-Diagnostics, Inc. Announces Third Quarter 2025 Earnings Release Date and Webcast

Co-Diagnostics Proxy statement: Proxy Filing

Oct 31, 2025, 8:00 AM EDT - 10 months ago

Co-Diagnostics Proxy statement: Proxy Filing

Co-Diagnostics to Host Fireside Chat on November 5th with CEO, Dwight Egan, to Discuss Recently Announced Definitive Agreement in Saudi Arabia

Oct 30, 2025, 1:57 PM EDT - 10 months ago

Co-Diagnostics to Host Fireside Chat on November 5th with CEO, Dwight Egan, to Discuss Recently Announced Definitive Agreement in Saudi Arabia

Co-Diagnostics, Inc. Announces Closing of $7.0 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

Oct 29, 2025, 12:51 PM EDT - 10 months ago

Co-Diagnostics, Inc. Announces Closing of $7.0 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

Co-Diagnostics, Inc. Announces Pricing of $7.0 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

Oct 28, 2025, 9:33 AM EDT - 10 months ago

Co-Diagnostics, Inc. Announces Pricing of $7.0 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

Co-Diagnostics Executive Leadership Team to Attend Global Health Exhibition 2025 in Riyadh, Saudi Arabia

Oct 22, 2025, 8:30 AM EDT - 10 months ago

Co-Diagnostics Executive Leadership Team to Attend Global Health Exhibition 2025 in Riyadh, Saudi Arabia

Co-Diagnostics Announces Development of Proprietary Sample Prep Instrument for PoC Testing

Oct 16, 2025, 9:30 AM EDT - 10 months ago

Co-Diagnostics Announces Development of Proprietary Sample Prep Instrument for PoC Testing

Co-Diagnostics, Inc. to Attend 2025 Maxim Growth Summit

Oct 13, 2025, 9:30 AM EDT - 11 months ago

Co-Diagnostics, Inc. to Attend 2025 Maxim Growth Summit

Bleedner
Bleedner Aug. 19 at 12:15 PM
$YJ $CODX 2 different sectors, I will bank on both of them. Mark it
0 · Reply
Bleedner
Bleedner Aug. 19 at 12:12 PM
$ARCT $VRAX $CODX All getting attention as MRNA sympathy plays
0 · Reply
Antiquarian
Antiquarian Aug. 19 at 12:06 PM
$CODX Posted 19 miserable hours ago “Subject to FDA clearance, Co-D is preparing for a potential U.S. launch of the platform, while also pursuing regulatory authorizations internationally and working toward the broader goal of expanding access to PCR diagnostics around the world. We appreciate the opportunity to join other industry leaders for an important conversation about technologies, trends and challenges shaping the next chapter of medical devices and innovation.” https://lnkd.in/p/eUn43XMr
0 · Reply
CoffeeRocks
CoffeeRocks Aug. 19 at 10:25 AM
$CODX https://share.google/piVnHyjnJ8HQpf69y
0 · Reply
ShangVXO
ShangVXO Aug. 19 at 9:20 AM
Been tapped into @_ProfessorGamma for a minute now. The way they spot some of these plays before they run is nuts! Wise to be paying attention to this account, give him a proper follow 👍 $LICN and $CODX can boom
0 · Reply
Dovkav
Dovkav Aug. 19 at 1:53 AM
$CODX covid is spreading. Hopefully it's good news for codx
1 · Reply
Stealth80
Stealth80 Aug. 18 at 10:46 PM
$CODX post 1/2 Before voting FOR everything simply because the Board recommends it, make sure you understand what you are approving. Here is what the six proposals actually mean: 1. Directors — BE CAREFUL You are voting on five individual Board members. You can vote for each director separately. The Board recommends FOR all five. 2. Equity Incentive Plan — PAY ATTENTION A FOR vote increases the number of common shares available for awards under the 2025 Equity Incentive Plan. This means shareholders are being asked to authorize additional shares for equity compensation. 3. Executive Compensation — PAY ATTENTION A FOR vote means supporting, on an advisory basis, the compensation paid to the Company’s named executive officers as described in the Proxy Statement.
1 · Reply
Stealth80
Stealth80 Aug. 18 at 10:45 PM
$CODX post 2/2 4. Auditor — PROCEDURAL A vote to ratify Tanner LLC as the Company's independent registered public accounting firm for 2026. 5. Quorum — PROCEDURAL A FOR vote changes the Articles of Incorporation so that one-third of the voting power constitutes a quorum. 6. Adjournment — PROCEDURAL A FOR vote allows the Annual Meeting to be postponed or adjourned if necessary to allow additional solicitation and voting of proxies in favor of the proposals. The Board recommends FOR all six proposals. So before clicking FOR ALL, read what you are actually approving. I am not telling anyone how to vote. I am simply pointing out that shareholders should not automatically approve every proposal without understanding its consequences. Read the Proxy. Understand the proposals. Then vote accordingly.
1 · Reply
MarioKou
MarioKou Aug. 18 at 10:24 PM
$CODX it's cold and lonely in here.
1 · Reply
FilthyPeasant
FilthyPeasant Aug. 18 at 7:38 PM
$CODX Study published recently in India which points out the large gap between TB diagnostic demand and the existing diagnostic infrastructure. Explicitly states the need for TB diagnostics technology at the point of primary care, essentially calling for our technology to be rolled out. It will be soon! Something like 25 million PCR TB tests/year are needed in the near future for India to transition from a 100 years old technique that nobody uses anymore. Looking forward to CDSCO approval news as the next big domino! https://theprint.in/ani-press-releases/indias-tb-elimination-goal-needs-stronger-diagnostic-infrastructure-at-the-point-of-care-peer-reviewed-study/3014647/
2 · Reply
Millones
Millones Aug. 18 at 7:25 PM
$CODX New all time low: $1.26 Or $0.04 pre reverse split
3 · Reply
LondonVentures
LondonVentures Aug. 18 at 5:57 PM
$CODX Thanks Dwight you Dwouche! Where do I get any slice of this? https://www.law360.com/healthcare-authority/deals-corporate-governance/articles/2514401/covid-test-maker-inks-6-5m-investor-deal-over-sales-slump
2 · Reply
Golferhack12
Golferhack12 Aug. 18 at 3:38 PM
$CODX the stock is trading at a new low the CEO is an idiot he hasn't been able to capitalize on any of this so-called technology since covid why would anybody buy this stock are you guys waiting for like Doomsday or something
2 · Reply
Nik_CA
Nik_CA Aug. 18 at 2:59 PM
$CODX How soon will it go - under $1🤔
3 · Reply
focafoca99
focafoca99 Aug. 18 at 1:55 PM
$CODX submitted a 510(k) premarket notification for its PCR Flu A/B & RSV test. https://www.rapidticker.com/news/codx-co-diagnostics-participates-in-medical-c59235
0 · Reply
Antiquarian
Antiquarian Aug. 18 at 1:31 PM
$CODX
2 · Reply
JimmyOcarri
JimmyOcarri Aug. 17 at 8:42 PM
$ALLR $CODX $CABR $SNOA $HUIZ game
1 · Reply
CoffeeRocks
CoffeeRocks Aug. 17 at 8:25 PM
$CODX Buys are here 1.35$S
1 · Reply
CoffeeRocks
CoffeeRocks Aug. 17 at 3:21 PM
$CODX Low R 1.3-1.35$S
0 · Reply
Antiquarian
Antiquarian Aug. 17 at 2:07 PM
$CODX Posted 2 miserable days ago “Our patriotism is reflected in our commitment to taking the best of Indian science and manufacturing to the global forefront. Driven by the legacy of one of India's science stalwarts, Dr. Vikram Sarabhai, we are proud to be ISO 13485-certified and CDSCO-compliant, and to operate a 30,000 sq. ft. facility in Vadodara that manufactures 52+ products and custom oligonucleotides from Indian soil. To us, celebrating the spirit of independence means making the best of diagnostic innovation accessible to India and the world.” https://www.linkedin.com/posts/cosara-diagnostics_independenceday-jaihind-madeinindia-activity-7494225245277618176-1k90?utm_medium=ios_app&rcm=ACoAAFjXGZcBhXwZH9_iFWZo5edPFCgnaenwTFM&utm_source=social_share_send&utm_campaign=copy_link
2 · Reply
Millones
Millones Aug. 17 at 1:04 PM
$CODX Oh, look. The same company selling our shares making a profit from commissions due to dilution also upgrades the analyst projections from hold to buy.
4 · Reply
CoffeeRocks
CoffeeRocks Aug. 17 at 12:15 PM
$EBS $CODX $AEMD $GOVX $VRAX https://share.google/URauLdlDxl7AA4l9k
0 · Reply